Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience.

Introduction: Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it. The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users.

Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users.

Introduction: There is discussion about the frequency of STI screening among pre-exposure prophylaxis (PrEP) users. The aim of this study was to analyse the incidence of STIs and to evaluate different screening models in order to optimise the follow-up.

Methodology: A prospective study was conducted between 2017 and 2023, including 138 PrEP users in a STI clinic.